- Raised grant led by Israel Innovation Authority, 2024
About
PerMe is a deep tech-based digital health platform focusing on DNA tests, aiming to make personalized health accessible. The company offers a simple, cheap, and fast single-use sensor that identifies genetic variations and provides digital results within minutes directly to the mobile phone without needing microelectronic components or a laboratory. The platform converts biological data into health recommendations. PerMe is driven by a team of experienced entrepreneurs and seeks to make DNA-based health solutions accessible to everyone. The company's innovative technology democratizes DNA testing, making personalized healthcare for disease detection, beauty, supplements, medication, pet care, sexual health recommendations, microbiome and age-related analysis, and Telehealth consultations accessible to all. Applying advanced data analytics and AI/ML on the big data collected will be the heart of healthcare innovation, understanding complex diseases and discovering new medicines. PERME Labs is endeavoring to release a product in 2027 that will revolutionize entire industries across various categories, such as Health care and wellness. This organization specializes in technology and science and operates laboratories in the United States and Israel.
Funding history · 1 round · — total
Offices
Q&A
- What is PerMe's primary focus?
- PerMe is a deep-tech digital health platform that develops disruptive innovation in home DNA testing, converting biological samples to digital information in real-time with an affordable device that does not require labs.
- When was PerMe founded?
- PerMe was founded in May 2022.
- Who are the founders of PerMe?
- The founders of PerMe are Yoav Rapaport (Founder & CEO) and Igal Chertkow (Founder & CTO).
- What is PerMe's current funding stage?
- PerMe is currently in the Pre-Seed funding stage.
- Which investors participated in PerMe's January 2025 funding round?
- Rhodium participated in PerMe's funding round in January 2025.
- Which investors participated in PerMe's September 2024 funding round?
- IL Angel Club participated in PerMe's funding round in September 2024.
- What technologies does PerMe utilize in its platform?
- PerMe utilizes Artificial Intelligence and Machine Learning in its platform.
Team · 14
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | permedna.com/ |
|---|---|
| linkedin.com/company/88676302 |
Identifiers & details
| Legal name | PerMe DNA |
|---|---|
| Founded | 2020 |
| Employees (exact) | 14 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Publications (Crossref)
| Works | 8 |
|---|
Web history (Wayback)
| Domain | permedna.com |
|---|
Certificate / subdomain footprint
| Subdomains | 5 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517140000 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2025-03-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | ציפורי 13 הרצליה |